Next Biomedical Co.,Ltd. is a South Korean company engaged in the research, development, and production of therapeutics, drug delivery systems, and drug-medical device products. Its offerings include hemostatic material for endoscopes and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea.